Tuberculosis Case Management Services. LPHA’s TB Case Management Services must include the following minimum components:
Tuberculosis Case Management Services. LPHA’s TB Case Management Services must include the following minimum components: LPHA must investigate and monitor treatment for each case and suspected case of active TB disease identified by or reported to LPHA whose residence is in LPHA’s jurisdiction, to confirm the diagnosis of TB and ensure completion of adequate therapy. LPHA must require individuals who reside in LPHA’s jurisdiction and who LPHA suspects of having active TB disease, to receive appropriate medical examinations and laboratory testing to confirm the diagnosis of TB and response to therapy, through the completion of treatment. LPHA must assist in arranging the laboratory testing and medical examination, as necessary. LPHA must provide medication for the treatment of TB to all individuals who reside in LPHA’s jurisdiction and who have TB but who do not have the means to purchase TB medications or for whom obtaining or using identified means is a barrier to TB treatment compliance. LPHA must monitor, at least monthly and in person, individuals receiving medication(s) for adherence to treatment guidelines, medication side effects, and clinical response to treatment. DOT is the standard of care for the treatment of TB. Cases of TB disease should be treated via DOT. If DOT is not utilized, The Department’s TB Program must be consulted. The Department’s TB Program must be consulted prior to initiation of any TB treatment regimen which is not recommended by the most current CDC, American Thoracic Society and Infectious Diseases Society of America TB treatment guideline. LPHA may assist the patient in completion of treatment by utilizing the below methods. Methods to ensure adherence should be documented. Proposed interventions for assisting the individual to overcome obstacles to treatment adherence (e.g. assistance with transportation).
